Calcification of coronary artery
|
phenotype |
Nutritional and Metabolic Diseases; Cardiovascular Diseases
|
Pathologic Function
|
51
|
205
|
0.100 |
None |
1.000 |
1 |
1
|
2012 |
2012 |
Amino acids measurement
|
group |
|
Laboratory Procedure
|
53
|
92
|
0.100 |
None |
1.000 |
1 |
1
|
2016 |
2016 |
Interleukin 16 Measurement
|
phenotype |
|
Laboratory Procedure
|
9
|
12
|
0.100 |
None |
1.000 |
1 |
1
|
2017 |
2017 |
Partial thromboplastin time increased (finding)
|
phenotype |
|
Finding
|
18
|
1
|
0.100 |
None |
|
0 |
|
|
|
BIETTI CRYSTALLINE CORNEORETINAL DYSTROPHY
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Eye Diseases
|
Disease or Syndrome
|
12
|
36
|
0.100 |
None |
|
0 |
6
|
|
|
Keratoderma, Palmoplantar
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
165
|
19
|
0.050 |
None |
1.000 |
5 |
|
1994 |
2019 |
Arthritis
|
disease |
Musculoskeletal Diseases
|
Disease or Syndrome
|
1072
|
69
|
0.030 |
None |
1.000 |
3 |
|
2017 |
2018 |
Diabetic Retinopathy
|
disease |
Eye Diseases; Endocrine System Diseases; Cardiovascular Diseases
|
Disease or Syndrome
|
645
|
213
|
0.020 |
None |
1.000 |
2 |
|
2018 |
2019 |
Middle Cerebral Artery Occlusion
|
disease |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Cardiovascular Diseases
|
Acquired Abnormality
|
626
|
|
0.020 |
None |
1.000 |
2 |
|
2017 |
2017 |
Hypertensive disease
|
group |
Cardiovascular Diseases
|
Disease or Syndrome
|
2322
|
1085
|
0.020 |
None |
1.000 |
2 |
2
|
2007 |
2016 |
Colitis
|
disease |
Digestive System Diseases
|
Disease or Syndrome
|
1135
|
15
|
0.020 |
None |
1.000 |
2 |
|
2018 |
2018 |
Deep Vein Thrombosis
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
230
|
93
|
0.020 |
None |
1.000 |
2 |
|
2008 |
2009 |
Kidney Failure, Chronic
|
disease |
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Disease or Syndrome
|
827
|
425
|
0.020 |
None |
1.000 |
2 |
2
|
1998 |
2000 |
Chronic kidney disease stage 5
|
disease |
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Disease or Syndrome
|
666
|
194
|
0.020 |
None |
1.000 |
2 |
2
|
1998 |
2000 |
Carcinoma of lung
|
disease |
Neoplasms; Respiratory Tract Diseases
|
Neoplastic Process
|
4081
|
1204
|
0.010 |
None |
1.000 |
1 |
|
2008 |
2008 |
Chronic idiopathic urticaria
|
disease |
Skin and Connective Tissue Diseases; Immune System Diseases
|
Disease or Syndrome
|
89
|
9
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
arthritis symptoms
|
disease |
|
Disease or Syndrome
|
9
|
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Breast Carcinoma
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
6776
|
2793
|
0.010 |
None |
1.000 |
1 |
|
1999 |
1999 |
Human immunodeficiency virus (HIV) II infection category B1
|
disease |
|
Disease or Syndrome
|
985
|
56
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Carcinogenesis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
6243
|
355
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Chemical Carcinogenesis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
71
|
2
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Primary malignant neoplasm of lung
|
disease |
Neoplasms; Respiratory Tract Diseases
|
Neoplastic Process
|
3894
|
981
|
0.010 |
None |
1.000 |
1 |
|
2008 |
2008 |
Diabetic macular edema
|
disease |
Eye Diseases; Endocrine System Diseases; Cardiovascular Diseases
|
Disease or Syndrome
|
92
|
6
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
hearing impairment
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Otorhinolaryngologic Diseases
|
Disease or Syndrome
|
740
|
337
|
0.010 |
None |
1.000 |
1 |
|
2001 |
2001 |
Hyperkeratosis
|
disease |
Pathological Conditions, Signs and Symptoms; Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
176
|
19
|
0.010 |
None |
1.000 |
1 |
|
1999 |
1999 |